187 research outputs found
Novel analgesic interventions in cancer-induced bone pain
Cancer-induced bone pain (CIBP), due to bony metastases, is a major clinical
problem, significantly reducing quality of life in cancer patients. Current therapies
often provide inadequate analgesia or unacceptable side effects. The aim of this
thesis was to characterise behaviours of a preclinical model of CIBP and test novel
analgesic interventions in this model. A secondary aim was to investigate the
involvement of the N-methyl-D-Aspartate (NMDA) receptors and TRP channels
(TRPM8, TRPV1 and TRPV4) in CIBP. Investigation of CIBP in a preclinical model
may lead to better pain management in CIBP patients.
The results presented here demonstrate that this model of CIBP develops
behaviours that may be indicative of mechanical allodynia, thermal sensitivity,
movement-evoked pain, ongoing pain and spontaneous pain. This suggests that this
model reflects the clinical condition of CIBP, where patients suffer from constant
background pain with spontaneous and movement-related breakthrough pain.
In this study it was found that radiotherapy significantly attenuated
movement-evoked pain and thermal sensitivity to 20Ā°C and 40Ā°C. XRT also
significantly reduced anxiety and risk assessment behaviours (grooming behaviour
and number of protected stretch attends) compared to untreated CIBP. Duloxetine
attenuated CIBP-induced mechanical allodynia, thermal sensitivity to 40Ā°C and
movement-evoked pain, whereas S,S-reboxetine attenuated thermal sensitivity to
40Ā°C but did not effect CIBP-induced mechanical allodynia or movement-evoked
pain. In addition, CB 65 attenuated movement-evoked pain and thermal sensitivity to
40Ā°C. A single dose of gabapentin did not attenuate CIBP-induced mechanical
allodynia, thermal sensitivity to 40Ā°C or movement-evoked pain. These studies
confirm that the CIBP model shows characteristics and pharmacological sensitivities
consistent with known and predicted mechanisms and validate it as a useful model
for assessing potential new treatments proposed for use in patients. Behavioural results suggest that NMDA receptors containing the NR2A
subunit are involved in CIBP-induced movement-evoked pain. This suggests that
NR2A antagonists may be useful for treating CIBP-induced movement-evoked pain.
Additionally, results show that there is increased expression of NR2A in the laminae
I, II and III in the dorsal horn of the spinal cord. XRT treated animals also showed
increased expression of NR2A in laminae I and II. The selective involvement of
NR2A in CIBP is different to other chronic pain states, for example, neuropathic pain
states that appear to involve the NR2B subunit.
The TRPV1 antagonist AMG 9810 did not attenuate mechanical allodynia,
thermal sensitivity to 40Ā°C or movement-evoked pain. Interestingly, the TRPM8
agonist icilin attenuated movement-evoked pain, which suggests that icilin might be
useful in the treatment of movement-evoked pain. The TRPV4 antagonist RN 1734
attenuated mechanical allodynia, thermal sensitivity to 40Ā°C and movement-evoked
pain in CIBP. This suggests RN 1734 may be useful in the treatment of mechanical
allodynia, thermal sensitivity to 40Ā°C and movement-evoked pain in CIBP. Results
show that the expression of TRPV4 is increased in DRG ipsilateral to the cancerbearing
tibia.
In conclusion, these results show that the preclinical model of CIBP
investigated in this thesis is suitable for testing novel analgesic interventions. This
thesis identified some useful targets for the analgesic treatment of CIBP and results
suggest that many different mechanisms contribute to CIBP. A point to consider is
that any robust effective treatment may need to target all (or at least several) of these
mechanisms
Process Evaluation of Community Energy Development Programme Projects
This report sets out the findings, conclusions and recommendations of a Process Evaluation, conducted between January and March 2015, of the Community Energy Development Programme (CEDP) projects as part of the Malawi Renewable Energy Acceleration Programme (MREAP). It was commissioned by the Scottish Government (SG) as a product of the Institutional Support Programme Component (ISP) of MREAP. Its main purpose is to assess what has been delivered, how this has been achieved and to compile learning from the process for policy and future projects. The agreed scope for the process evaluation was the portfolio of 46 CEDP projects implemented across the 3 regions of Malawi and the relevant processes and systems in place to design, implement and manage these projects. Due consideration was also given to framing the scope of the evaluation through the choice of evaluation questions and the feasibility of what was possible
Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency
In obese humans, metabolism of glucocorticoids by 11Ī²-hydroxysteroid dehydrogenase type 1 (11Ī²-HSD1) and A-ring reduction (by 5Ī±- and 5Ī²-reductases) is dysregulated in a tissue specific manner. These changes have been recapitulated in leptin resistant obese Zucker rats but were not observed in high-fat fed Wistar rats. Recent data from mouse models suggest that such discrepancies may reflect differences in leptin signalling. We therefore compared glucocorticoid metabolism in murine models of leptin deficiency and resistance. Male ob/ob and db/db mice and their respective littermate controls (n=10ā12/group) were studied at the age of 12 weeks. Enzyme activities and mRNA expression were quantified in snap-frozen tissues. The patterns of altered pathways of steroid metabolism in obesity were similar in ob/ob and db/db mice. In liver, 5Ī²-reductase activity and mRNA were increased and 11Ī²-HSD1 decreased in obese mice, whereas 5Ī±-reductase 1 (5Ī±R1) mRNA was not altered. In visceral adipose depots, 5Ī²-reductase was not expressed, 11Ī²-HSD1 activity was increased and 5Ī±R1 mRNA was not altered in obesity. By contrast, in subcutaneous adipose tissue 11Ī²-HSD1 and 5Ī±R1 mRNA were decreased. Systematic differences were not found between ob/ob and db/db murine models of obesity, suggesting that variations in leptin signalling through the short splice variant of the Ob receptor do not contribute to dysregulation of glucocorticoid metabolism
Designing, conducting, and reporting reproducible animal experiments
In biomedicine and many other fields, there are growing concerns around the reproducibility of research findings, with many researchers being unable to replicate their own or others' results. This raises important questions as to the validity and usefulness of much published research. In this review, we aim to engage researchers in the issue of research reproducibility and equip them with the necessary tools to increase the reproducibility of their research. We first highlight the causes and potential impact of non-reproducible research and emphasise the benefits of working reproducibly for the researcher and broader research community. We address specific targets for improvement and steps that individual researchers can take to increase the reproducibility of their work. We next provide recommendations for improving the design and conduct of experiments, focusing on in vivo animal experiments. We describe common sources of poor internal validity of experiments and offer practical guidance for limiting these potential sources of bias at different experimental stages, as well as discussing other important considerations during experimental design. We provide a list of key resources available to researchers to improve experimental design, conduct, and reporting. We then discuss the importance of open research practices such as study preregistration and the use of preprints and describe recommendations around data management and sharing. Our review emphasises the importance of reproducible work and aims to empower every individual researcher to contribute to the reproducibility of research in their field.</p
Data Reduction Pipeline for the CHARIS Integral-Field Spectrograph I: Detector Readout Calibration and Data Cube Extraction
We present the data reduction pipeline for CHARIS, a high-contrast
integral-field spectrograph for the Subaru Telescope. The pipeline constructs a
ramp from the raw reads using the measured nonlinear pixel response, and
reconstructs the data cube using one of three extraction algorithms: aperture
photometry, optimal extraction, or fitting. We measure and apply both
a detector flatfield and a lenslet flatfield and reconstruct the wavelength-
and position-dependent lenslet point-spread function (PSF) from images taken
with a tunable laser. We use these measured PSFs to implement a -based
extraction of the data cube, with typical residuals of ~5% due to imperfect
models of the undersampled lenslet PSFs. The full two-dimensional residual of
the extraction allows us to model and remove correlated read noise,
dramatically improving CHARIS' performance. The extraction produces a
data cube that has been deconvolved with the line-spread function, and never
performs any interpolations of either the data or the individual lenslet
spectra. The extracted data cube also includes uncertainties for each spatial
and spectral measurement. CHARIS' software is parallelized, written in Python
and Cython, and freely available on github with a separate documentation page.
Astrometric and spectrophotometric calibrations of the data cubes and PSF
subtraction will be treated in a forthcoming paper.Comment: 18 pages, 15 figures, 3 tables, replaced with JATIS accepted version
(emulateapj formatted here). Software at
https://github.com/PrincetonUniversity/charis-dep and documentation at
http://princetonuniversity.github.io/charis-de
Systematic reviews and meta-analysis of preclinical studies:why perform them and how to appraise them critically
The use of systematic review and meta-analysis of preclinical studies has become more common, including those of studies describing the modeling of cerebrovascular diseases. Empirical evidence suggests that too many preclinical experiments lack methodological rigor, and this leads to inflated treatment effects. The aim of this review is to describe the concepts of systematic review and meta-analysis and consider how these tools may be used to provide empirical evidence to spur the field to improve the rigor of the conduct and reporting of preclinical research akin to their use in improving the conduct and reporting of randomized controlled trials in clinical research. As with other research domains, systematic reviews are subject to bias. Therefore, we have also suggested guidance for their conduct, reporting, and critical appraisal
- ā¦